Literature DB >> 19566416

History of the medical use of silver.

J Wesley Alexander1.   

Abstract

BACKGROUND: Silver has been used extensively throughout recorded history for a variety of medical purposes.
METHODS: A review of the literature in English was undertaken, primarily using PUBMED, to identify the medical uses of silver before the clinical introduction of antibiotics in the 1940s.
RESULTS: Silver has been used for at least six millennia to prevent microbial infections. It has been effective against almost all organisms tested and has been used to treat numerous infections and noninfectious conditions, sometimes with striking success. Silver also has played an important role in the development of radiology and in improving wound healing.
CONCLUSION: Silver was the most important antimicrobial agent available before the introduction of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19566416     DOI: 10.1089/sur.2008.9941

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  98 in total

Review 1.  Silver-coated megaprostheses: review of the literature.

Authors:  Tom Schmidt-Braekling; Arne Streitbuerger; Georg Gosheger; Friedrich Boettner; Markus Nottrott; Helmut Ahrens; Ralf Dieckmann; Wiebke Guder; Dimosthenis Andreou; Gregor Hauschild; Burkhard Moellenbeck; Wenzel Waldstein; Jendrik Hardes
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-06

Review 2.  Antimicrobial activity of metals: mechanisms, molecular targets and applications.

Authors:  Joseph A Lemire; Joe J Harrison; Raymond J Turner
Journal:  Nat Rev Microbiol       Date:  2013-05-13       Impact factor: 60.633

3.  Determination of antibacterial properties and cytocompatibility of silver-loaded coral hydroxyapatite.

Authors:  Yu Zhang; Qing-Shui Yin; Yu Zhang; Hong Xia; Fu-Zhi Ai; Yan-Peng Jiao; Xu-Qiong Chen
Journal:  J Mater Sci Mater Med       Date:  2010-06-05       Impact factor: 3.896

4.  Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?

Authors:  Maria S Zharkova; Dmitriy S Orlov; Olga Yu Golubeva; Oleg B Chakchir; Igor E Eliseev; Tatyana M Grinchuk; Olga V Shamova
Journal:  Front Cell Infect Microbiol       Date:  2019-04-30       Impact factor: 5.293

5.  New TiAg composite coating for bone prosthesis engineering shows promising microvascular compatibility in the murine dorsal skinfold chamber model.

Authors:  Ann-Kathrin Behrendt; Maximilian Beythien; Jakob Huber; Thorsten Zufraß; Antje Butschkau; Thomas Mittlmeier; Brigitte Vollmar
Journal:  J Mater Sci Mater Med       Date:  2015-01-15       Impact factor: 3.896

Review 6.  Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.

Authors:  Henry A Havel
Journal:  AAPS J       Date:  2016-08-12       Impact factor: 4.009

Review 7.  [Surface modifications of implants. Part 2 : Clinical application].

Authors:  Marcus Jäger
Journal:  Orthopade       Date:  2018-05       Impact factor: 1.087

8.  Evaluation of the temporary effect of physical vapor deposition silver coating on resistance to infection in transdermal skin and bone integrated pylon with deep porosity.

Authors:  Maxim A Shevtsov; Natalia M Yudintceva; Miralda I Blinova; Irina V Voronkina; Dmitriy N Suslov; Oleg V Galibin; Dmitriy V Gavrilov; Michael Akkaoui; Grigoriy Raykhtsaum; Andrey V Albul; Emil Pitkin; Mark Pitkin
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2018-03-23       Impact factor: 3.368

9.  Silver oxynitrate, an unexplored silver compound with antimicrobial and antibiofilm activity.

Authors:  Joe A Lemire; Lindsay Kalan; Alexandru Bradu; Raymond J Turner
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

Review 10.  Use of silver in the prevention and treatment of infections: silver review.

Authors:  Amani D Politano; Kristin T Campbell; Laura H Rosenberger; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2013-02-28       Impact factor: 2.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.